Bortezomib, thalidomide and dexamethasone versus bortezomib, cyclophosphamide and dexamethasone as induction therapy prior to ASCT in multiple myeloma - response to Moreau et al

Bortezomib-Cyclophosphamide-Dexamethason

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) versus Bortezomib-Thalidomide-Dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysis

✍ Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Bortezomib-Cyclophosphamide-Dexamethason

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) versus Bortezomib-Thalidomide-Dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysis

✍ Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Randomized Phase II Study of Bortezomib,

Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma

✍ Ludwig, H.; Viterbo, L.; Greil, R.; Masszi, T.; Spicka, I.; Shpilberg, O.; Hajek 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 262 KB

Superiority of bortezomib, thalidomide,

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

✍ Rosiñol, Laura (author);Oriol, Albert (author);Teruel, Ana Isabel (author);Herná 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 312 KB

Superiority of bortezomib, thalidomide,

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

✍ Rosiñol, Laura (author);Oriol, Albert (author);Teruel, Ana Isabel (author);Herná 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 312 KB

The efficacy and safety of bortezomib an

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

✍ Giulia Benevolo; Alessandra Larocca; Massimo Gentile; Patrizia Pregno; Francesca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views